CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanxi Zhendong Pharmaceutical Co Ltd Company Snapshot
Shanxi Zhendong Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi Zhendong Pharmaceutical Co Ltd with three other companies in this sector in China: ChangChun High New Technology Industries (2016 sales of 2.87 billion Chinese Renmimbi [US$433.67 million] of which 81% was Medication), Shandong Xinhua Pharmaceutical Company Limited (4.01 billion Chinese Renmimbi [US$605.85 million] of which 44% was Chemical Raw Medicine), and Shandong Lukang Pharmaceutical (2.51 billion Chinese Renmimbi [US$378.04 million] of which 67% was Human Antibiotic).

Sales Analysis. During the year ended December of 2016, sales at Shanxi Zhendong Pharmaceutical Co Ltd were 3.28 billion Chinese Renmimbi (US$495.27 million). This is an increase of 45.1% versus 2015, when the company's sales were 2.26 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shanxi Zhendong Pharmaceutical Co Ltd (and since 2011, sales have increased a total of 156%). Sales of Medicinal Curb Planting saw an increase of 71.0% in 2016, from 104.73 million Chinese Renmimbi to 179.07 million Chinese Renmimbi. Not all segments of Shanxi Zhendong Pharmaceutical Co Ltd experienced an increase in sales in 2016: sales of Other fell 23.4% to 11.20 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanxi Zhendong Pharmaceutical Co Ltd
  Stock Performance Chart for Shanxi Zhendong Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2017): 16.88
(Figures in Chinese Renmimbi)
1 Week -2.3%   13 Weeks 0.7%  
4 Weeks 3.5%   52 Weeks -12.3%  
 
Shanxi Zhendong Pharmaceutical Co Ltd Key Data:
  Ticker: 300158 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 3,282,096,662
(Year Ending Jan 2017).
Employees: 4,042
  Currency: Chinese Renmimbi Market Cap: 8,769,655,090
  Fiscal Yr Ends: December Shares Outstanding: 519,529,330
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.